Remdesivir for COVID-19 improves time to recovery, peer-reviewed data shows

Remdesivir is superior to the standard of care for the treatment of COVID-19, according to a preliminary analysis based on data from a randomized, controlled trial. Researchers found that the antiviral was most beneficial for hospitalized patients with severe disease who required supplemental oxygen.

from Health & Medicine News -- ScienceDaily https://ift.tt/3gtsluU